Showing results (1-10 of 5,028) with videos related to

Sort By:
Pageof 503
Gan No Rinsho. Japan Journal of Cancer Clinics|October 1, 1988
[Radiosensitizing effects of perfluorochemicals]T Hasegawa, K Harima, Y Tanaka
Cardiovascular and Interventional Radiology|January 1, 1995
Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplantsK Harima, Y Harima, T Hasegawa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Histopathological changes in rabbit uterus carcinoma after transcatheter arterial embolization using cisplatinY Harima, K Harima, T Hasegawa, et al.
Anticancer Research|January 1, 1996
Transcatheter arterial embolization with cisplatin: apoptosis in VX2 tumour uterus transplantsY Harima, K Harima, T Hasegawa, et al.
Gynecologic Oncology|October 1, 1990
Advanced vulvar carcinoma treated with internal iliac arterial embolization therapy after radiotherapyY Harima, T Shiraishi, K Harima, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|August 25, 1991
[Long-term results of transcatheter arterial embolization therapy in cases of recurrent and advanced pelvic cancer]Y Harima, T Shiraishi, K Harima, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|January 25, 1990
[Transcatheter arterial embolization therapy in cases of recurrent and advanced pelvic cancer--estimation by Cox's proportional hazard model]Y Harima, T Shiraishi, K Harima, et al.
British Journal of Cancer|September 16, 1999
Genetic alterations on chromosome 17p associated with response to radiotherapy in bulky cervical cancerY Harima, S Shirahama, K Harima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancerY Harima, K Harima, S Sawada, et al.
Pageof 503